Essay proposes tracking online cannabis spread to guide prevention, not prove…

Rethinking Substance Use Spread in the Platform Era: A Communicable Disease Framework.

American journal of public health • • Highly Relevant
🤖

AI Summary

This essay asks whether a communicable-disease framework can help explain how cannabis and psychedelics spread in the platform era. Rather than reporting a new experiment or clinical trial, it revisits an earlier model that tracks chains and speed of transmission, and proposes using it as a heuristic alongside prevention and health-system responses. The authors argue that digital platforms can amplify personal accounts of substance use, while prevention efforts have not kept pace.

For cannabis, the abstract says normalization appears to have outpaced treatment capacity and reports that approximately 19 million Americans meet criteria for cannabis use disorder, with service-delivery infrastructure not scaled to that prevalence. The essay proposes an updated prevention framework; it does not test whether that framework works or establish that online platforms cause substance use. This is an abstract-based summary: the abstract does not provide study methods or new quantitative results, so it cannot establish the size of platform effects or the effectiveness of the proposed approach.

💡 Key Findings

1
The essay proposes adapting a communicable-disease framework to trace how cannabis and psychedelics spread through digital platforms and to connect transmission patterns with prevention and health-system responses.
High
95%
2
The abstract reports approximately 19 million Americans meet criteria for cannabis use disorder and argues that treatment infrastructure has not scaled to that prevalence.
High
95%
3
The authors argue that personal testimony amplified by digital platforms may contribute to substance-use propagation, but this essay does not establish that platforms cause use or test whether its proposed prevention framework is effective.
High
95%

📄 Original Abstract

Substance use has long been understood as spreading through person-to-person transmission. Treatment (secondary and tertiary prevention) is a legitimate priority, but no epidemic, from cholera through COVID-19, has been curtailed by treatment alone. For substance use, prevention infrastructure remains disconnected from the environments in which use now propagates. The communicable disease model, which traces incidence chains and propagation velocity, served heroin outbreak analysis in the 1960s and 1970s but receded as surveillance turned to prevalence estimation. This essay revisits it, as a heuristic, for 2 contemporary cases: cannabis and psychedelics. Both appear to propagate through digital platforms that amplify personal testimony at unprecedented scale, while platform-adapted prevention infrastructure lags. Cannabis normalization appears to have outpaced treatment capacity, with approximately 19 million Americans meeting criteria for cannabis use disorder and service-delivery infrastructure unscaled to that prevalence. Psychedelic use is accelerating amid evolving clinical understanding of its harms. An updated framework anchored in the platform era, pairing transmission cascades with multilevel prevention and health-system response, may supply the primary prevention architecture that populations exposed to commercial and algorithmic promotion now lack. (Am J Public Health. Published online ahead of print November 5, 2026:e1-e7. https://doi.org/10.2105/AJPH.2026.308798).

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.